Natural products as lead compounds in drug discovery

Journal of Asian Natural Products Research

Volumn 15, Issue 7, 2013, Pages 764-788

  Khazir, Jabeena ^a,b   Mir, Bilal Ahmad ^b   Mir, Shabir Ahmad ^c   Cowan, Don ^b  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

anti infective; anticancer; drugs; lead compound; natural products

Indexed keywords

21 AMINOEPOTHILONE B; ACRONINE; BETULIC ACID; BRYOSTATIN; CABAZITAXEL; CAMPTOTHECIN; COMBRETASTATIN; COMBRETASTATIN A4; CURCUMIN; DAIDZEIN; DIFLOMOTECAN; ELOMOTECAN; FLAVOPIRIDOL; GENISTEIN; HOMOHARRINGTONINE; LURTOTECAN; MITOFLAXONE; NATURAL PRODUCT; NAVELBINE; OLEANOLIC ACID; PACLITAXEL; PENICILLIN G; PODOPHYLLOTOXIN; RUBITECAN; SILIBININ; TETRACYCLINE; TOPOTECAN; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

ANTIFUNGAL ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CAMPTOTHECA; CANCER CHEMOTHERAPY; CANDIDA ALBICANS; CATHARANTHUS ROSEUS; CELL DEATH; DENGUE; DNA DAMAGE; DNA REPLICATION; DNA TRANSCRIPTION; DRUG DEVELOPMENT; DRUG SCREENING; DRUG STRUCTURE; EBOLA HEMORRHAGIC FEVER; HEPATITIS B; HEPATITIS C; INFLUENZA; INULA; LARGE CELL LYMPHOMA; MITOSIS; NONHUMAN; PENICILLIUM CHRYSOGENUM; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PODOPHYLLUM; PSEUDOMONAS AERUGINOSA; SACCHAROPOLYSPORA; SCIENTIST; SORANGIUM CELLULOSUM; SPECIES DIVERSITY; SPISULA; STREPTOCOCCUS PNEUMONIA; STREPTOMYCES AUREOFACIENS; STREPTOMYCES HYGROSCOPICUS; STRUCTURE ANALYSIS; TAXUS BREVIFOLIA;

FUNGI;

EID: 84880196857     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2013.798314     Document Type: Article

References (209)

1. R.J. Huxtable and S.K.W. Schwarz, Mol. Interv. 1, 189 (2001).
2. G. Lockemann, J. Chem. Educ. 28, 277 (1951).
3. M. Hesse, Alkaloids-Naturés Curse or Blessing (Verlag Helvetica Chimica Acta, Zurich and Wiley-VCH Verlag GmBH, Weinheim, 2002), p. 5.
4. D.J. Newman and G.M. Cragg, J. Nat. Prod. 70, 461 (2007).
5. A.K. Mukherjee, S. Basu, N. Sarkat, and A.C. Ghosh, Curr. Med. Chem. 8, 1467 (2001).
6. K.H. Lee, Med. Res. Rev. 19, 569 (1999).
7. I. Paterson and E.A. Anderson, Science 310, 451 (2005).
8. F.E. Koehn and G.T. Carter, Nat. Rev. Drug Discov. 4, 206 (2005).
9. K.H. Lee, J. Nat. Prod. 67, 273 (2004).
10. M.S. Butler, Nat. Prod. Rep. 22, 162 (2005).
11. M.S. Butler, J. Nat. Prod. 67, 2141 (2004).
12. M. Gordon, G.M. Cragg, D.J. Newman, and J. Rosenthal, Nat. Prod. Rep. 29, 1407 (2012).
13. G.M. Cragg, D.J.I. Kingston, D.J. Newman, Anticancer Agents from Natural Products (CRC Press, Boca Raton, FL, 2005), pp. 1-577.
14. M.S. Butler, Nat. Prod. Rep. 25, 475 (2008).
15. G.M. Cragg and D.J. Newman, J. Ethnopharmacol. 100, 72 (2005).
16. A. Kruczynski, J.M. Barret, C. Etievant, F. Colpaert, J. Fahy, and B.T. Hill, Biochem. Pharmacol. 55, 635 (1998).
17. Y.H. Hsiang, R. Hertzberg, S. Hecht, and L.F. Liu, J. Biol. Chem. 260, 4873 (1985).
18. N.H. Oberlies and D.J. Kroll, J. Nat. Prod. 67, 129 (2004).
19. A. Daud, N. Valkov, B. Centeno, J. Derderian, P. Sullivan, P. Munster, P. Urbas, R.C. DeConti, E. Berghorn, Z. Liu, F. Hausheer, and D. Sullivan, Clin. Cancer Res. 11, 3009 (2005).
20. N.M. Pamela and I.D. Adil, Expert Opin. Investig. Drugs 20, 1565 (2011).
21. J.R. Kroep and H. Gelderblom, Expert Opin. Investig. Drugs 18, 69 (2009).
22. S. Pecorelli, I. Ray-Coquard, O. Tredan, N. Colombo, G. Parma, G. Tisi, D. Katsaros, C. Lhomme, A.A. Lissoni, J.B. Vermorken, A. Bois, A. Poveda, L. Frigerio, P. Barbieri, P. Carminati, S. Brienza, and J.P. Guastalla, Ann. Oncol. 21, 759 (2010).
23. J. Hu, P.Y. Wen, L.E. Abrey, C.E. Fadul, J. Drappatz, N. Salem, J.G. Supko, and F. Hochberg, J. Neuro. Oncol. 111, 347 (2013).
24. I.F. Troconiz, J. Cendros, E. Soto, J. Prunonosa, A.P. Mayoral, C. Peraire, P. Principe, P. Delavault, F. Cvitkovic, T. Lesimple, and R. Obach, Cancer Chemother. Pharmacol. 70, 239 (2012).
25. A. Chatterjee, R. Digumarti, K. Katneni, V.V. Upreti, R.N. Mamidi, R. Mullangi, A. Surath, M.L. Sriniva, S. Uppalapati, S. Jiwatani, and N.R. Srinivas, J. Clin. Pharmacol. 45, 453 (2005).
26. T.F. Imbert, Biochimie 80, 207 (1998).
27. L.B. Wilson, S.B. Mizel, I.M. Grisham, and K.M. Creswell, Fed. Proc. Fed. Am. Soc. Exp. Biol. 33, 158 (1974).
28. V.N. Srivastava, A.S. Kumar, J.K. Gupta, and M.M. Khanuja, Bioorg. Med. Chem. 13, 5892 (2005).
29. P.J. Odwyer, B. Leylandjones, M.T. Alonso, S. Marsoni, R.E. Wittes, and N. Engl, J. Med. 312, 692 (1985).
30. M. Jacoby, Taxol. Chem. Eng. News 83, 120 (2005).
31. M.C. Wani, H.L. Taylor, M. Wall, P. Coggon, and A.T. McPall, J. Am. Chem. Soc. 93, 2325 (1971).
32. P.B. Schiff, J. Fant, and S.B. Horwitz, Nature 277, 665 (1979).
33. L. Wilson and M. Jordan, Chem. Biol. 2, 569 (1995).
34. A.D. Kinghorn and E.K. Seo, Non Food Ind. Appl. 647, 179 (1996).
35. R.H. Cichewitz and S.A. Kouzi, Med. Res. Rev. 24, 90 (2004).
36. FDA Approval for Cabazitaxel,
37. Clinicaltrials.gov: A service of the U.S. National Institutes of Health,
38. P. Zatloukal, R. Gervais, J. Vansteenkiste, L. Bosquee, C. Sessa, E. Brain, E. Dansin, T. Urban, N. Dohollou, M. Besenval, and E. Quoix, J. Thorac. Oncol. 3, 894 (2008).
39. Clinicaltrials.gov: A service of the U.S. National Institutes of Health,
40. M. Payne, P. Ellis, D. Dunlop, M. Ranson, S. Danson, L. Schacter, and D. Talbot, J. Thorac Oncol. 1, 984 (2006).
41. A.Y. Bedikian, R.C. DeConti, R. Conry, S. Agarwala, N. Papadopoulos, K.B. Kim, and M. Ernstoff, Ann. Oncol. 22, 787 (2011).
42. R.J. Jones, R.E. Hawkins, M.M. Eatock, D.R. Ferry, F.A. Eskens, H. Wilke, and T.R. Evans, Cancer Chemother. Pharmacol. 61, 435 (2008).
43. D. Sano, H. Matsuda, Y. Ishiguro, G. Nishimura, M. Kawakami, and M. Tsukuda, Oncol. Rep. 15, 329 (2006).
44. R.K. Ramanathan, J. Picus, H. Raftopoulos, S. Bernard, A.C. Lockhart, G. Frenette, J. Macdonald, S. Melin, D. Berg, F. Brescia, H. Hochster, and A. Cohn, Cancer Chemother. Pharmacol. 61, 453 (2008).
45. T. Mekhail, P. Serwatowski, A. Dudek, C. Belani, R. Jankowska, K.J. Pandya, S. Arnold, J. Brahmer, B. Gitlitz, and R. Govindan, J. Clin. Oncol. 24, 7098 (2006).
46. M. Roche, H. Kyriakou, and M. Seiden, Curr. Opin. Invest. Drugs 7, 1092 (2006).
47. M.N. Fishman, C.R. Garrett, G.R. Simon, A.A. Chiappori, R.M. Lush, W.R. Dinwoodie, J.J. Mahany, A.M. Dellaportas, A. Cantor, A. Gollerki, M.B. Cohen, and D.M. Sullivan, Clin. Cancer Res. 12, 523 (2006).
48. Clinicaltrials.gov: A service of the U.S. National Institutes of Health, Clinical- Trials.gov Identifier: NCT01505608.
49. A.D. Kinghorn and E.K. Seo, Agric. Mater. Renewable Res. 647, 179 (1996).
50. A.D. Harmon, U. Weiss, and J.V. Silverton, Tetrahedron Lett. 20, 721 (1979).
51. M. Patel, S. Nambiar, P. Vaidayanathan, T.R. Bheemanahally, R. Gudasalamani, N.G. Kotiganahalli, V. Ramesh, M. John, R.S. Thankayyan, P.D. Mishra, R. Viswakarma, and U.S. Ramanan, Fitoterapia 81, 145 (2010).
52. Sanofi-Aventis: Further information available at http://www.en. sanofiaventis.com/ (accessed on 14.12.2010).
53. L. Coward, N.C. Barnes, K.D.R. Setchell, and S. Barnes, J. Agric. Food Chem. 41, 196 (1993).
54. A.I. Constantinou and A. Husband, Anticancer Res. 22, 2581 (2002).
55. A.I. Constantinou, R. Mehta, and A. Husband, Eur. J. Cancer. 39, 1012 (2003).
56. D.J. Morre, P.J. Chueh, K. Yagiz, A. Balicki, C. Kim, and D.M. Morre, Oncol. Res. 16, 299 (2007).
57. G. Mor, H.H. Fu, and A.B. Alvero, Curr. Opin. Invest. Drugs 7, 542 (2006).
58. http://www.en.wikipedia.org/wiki/Genistein (accessed on 14.12.2010); for further information: http://www.newsrx.com/search-results.php?doSearch1&cat= a&search-term=Genistein&x=0&y=0
59. G.W. Rewcastle, G.J. Atwell, B.C. Baguley, S.B. Calveley, and W.A. Denny, J. Med. Chem. 32, 793 (1989).
60. G.W. Rewcastle, G.J. Atwell, L. Zhuang, B.C. Baguley, and W.A. Denny, J. Med. Chem. 34, 217 (1991).
61. A. Wallace, D.F. LaRosa, V. Kapoor, J. Sun, G. Cheng, A. Jassar, A. Blouin, L.M. Ching, and S.M. Albelda, Cancer Res. 67, 7011 (2007).
62. M.J. McKeage, Exp. Opin. Invest. Drugs 17, 23 (2008).
63. Antisoma: Further information available at http://www.antisoma.com/ (accessed on 14.12.2010).
64. M. Provinciali, F. Papalini, F. Orlando, S. Pierpaoli, A. Donnini, P. Morazzoni, A. Riva, and A. Smorlesi, Cancer Res. 67, 2022 (2007).
65. R. Gazak, D. Walterova, and V. Kren, Curr. Med. Chem. 14, 315 (2007).
66. M.J. Mokhtari, N. Motamed, and M.A. Shokrgozar, Cell Biol. Int. 32, 888 (2008).
67. N. Bhatia, J. Zhao, D.M. Wolf, and R. Agarwal, Cancer Lett. 147, 77 (1999).
68. F.S. Hogan, N.K. Krishnegowda, M. Mikhailova, and M.S. Kahlenberg, J. Surg. Res. 143, 58 (2007).
69. G. Sharma, R.P. Singh, D.C. Chan, and R. Agarwal, Anticancer Res. 23, 2649 (2003).
70. M. Athar, J.H. Back, X. Tang, K.H. Kim, L. Kopelovich, D.R. Bickers, and A.L. Kim, Toxicol. Appl. Pharmacol. 224, 274 (2007).
71. C.A. Lastra and I. Villegas, Biochem. Soc. Trans. 35, 1156 (2007).
72. H. Hatcher, R. Planalp, J. Cho, F.M. Torti, and S.V. Torti, Cell Mol. Life Sci. 65, 1631 (2008).
73. J. Liu, J. Ethnopharmacol. 49, 57 (1995).
74. R. Ahmad, D. Raina, C. Meyer, S. Kharbanda, and D. Kufe, J. Biol. Chem. 281, 35764 (2006).
75. E. Pisha, H. Chai, I.S. Lee, T.E. Chagwedera, N.R. Farnsworth, G.A. Cordell, C.W.W. Beecher, H.H.S. Fong, A.D. Kinghorn, D.M. Brown, M.C. Wani, M.E. Wall, T.J. Hieken, T.K. Gupta, and J.M. Pezzuto, Nat. Med. 1, 1046 (1995).
76. A. Sami, M. Taru, K. Salme, and Y.K. Jari, Eur. J. Pharm. Sci. 29, 1 (2006).
77. S. Chintharlapalli, S. Papineni, S.K. Ramaiah, and S. Safe, Cancer Res. 67, 2816 (2007).
78. E. Escalona-Benz, M.E. Jockovich, T.G. Murray, B. Hayden, E. Hernandez, W. Feuer, and J.J. Windle, Invest. Ophthalmol. Vis. Sci. 46, 8 (2005).
79. S. Aprile, E.D. Grosso, and G. Grosa, Drug Metab. Dispos. 38, 1141 (2010).
80. G.R. Pettit, C. Temple, V.L. Narayanan, R. Varma, M.J. Simpson, M.R. Boyd, G.A. Rener, and N. Bansal, Anticancer Drug Des. 10, 299 (1995).
81. S.L. Young and D.J. Chaplin, Exp. Opin. Invest. Drugs 13, 1171 (2004).
82. N. Mahindroo, J.P. Liou, J.Y. Chang, and H.P. Hsieh, Exp. Opin. Ther. Pat. 16, 647 (2006).
83. P. Hinnen and F.A. Eskens, Br. J. Cancer 96, 1159 (2007).
84. Oxigene: Press release 17 November 2009. Available at http://www.investor.oxigene.com/
85. J. Hohmann, F. Evanics, L. Berta, and T. Bartok, Planta Med. 66, 291 (2000).
86. A. Ivanova, K.I. Goldberg, Z. Kamenarska, J. Nechev, Z. Cohen, S. Popov, and K. Stefanov, Z. Naturforsch. 58c, 783 (2003).
87. S.M. Ogbourne, A. Suhrbier, B. Jones, S.J. Cozzi, G.M. Boyle, M. Morris, J. McAlpine, T.M. Johns, K.P. Scott, J.M. Sutherland, T.T.T. Gardner, A. Le, D. Lenarczyk, J.H. Aylward, and P.G. Parsons, Cancer Res. 64, 2833 (2004).
88. J.M. Challacombe, A. Suhrbier, P.G. Parsons, B. Jones, P. Hampson, D. Kavanagh, G.E. Rainger, M. Morris, J.M. Lord, T.T.T. Le, D. Hoang-Le, and S.M. Ogbourne, J. Immunol. 177, 8123 (2006).
89. S.M. Ogbourne, P. Hampson, J.M. Lord, P. Parsons, P.A. De Witte, and A. Suhrbier, Anti-Cancer Drugs 18, 357 (2007).
90. E. Ersvaer, A.O. Kittang, P. Hampson, K. Sand, B.T. Gjertsen, J.M. Lord, and O. Bruserud, Toxins 2, 174 (2010).
91. S. Michel, T. Gaslonde, and F. Tillequin, Eur. J. Med. Chem. 39, 649 (2004).
92. C.R. Garrett, M.N. Fishman, R.R. Rago, C.C. Williams, A.M. Dellaportas, J.J. Mahany, R.M. Lush, W.S. Dalton, A. Gollerkeri, M.B. Cohen, and D.M. Sullivan, Clin. Cancer Res. 11, 3335 (2005).
93. F. Tillequin, Phytochem. Rev. 6, 65 (2007).
94. A. Quintas-Cardama, H. Kantarjian, G. Garcia-Manero, S. O'Brien, S. Fader, Z. Estrov, F. Giles, A. Murgo, N. Ladie, S. Verstovsek, and J. Cortes, Cancer 109, 248 (2007).
95. D.J. Newman, G.M. Cragg, and K.M. Snader, J. Nat. Prod. 66, 1022 (2003).
96. W. Sneader, Drug Discovery: A History (John Wiley & Sons, Hoboken, NJ, 2005), pp. 188-225.
97. T.M. Chapman and C.M. Perry, Drugs 64, 861 (2004).
98. J. Portugal, Curr. Med. Chem. Anticancer Agents 3, 411 (2003).
99. K.S. Lam, J.A. Veitch, S. Forenza, C.M. Combs, and K.L. Colson, J. Nat. Prod. 52, 1015 (1989).
100. J. Verweij, J. Wanders, A.L. Nielsen, N. Pavlidis, F. Calabresi, W.B. Huinink, U. Bruntsch, M. Piccart, H. Franklin, and S.B. Kaye, Ann. Oncol. 5, 375 (1994).
101. M. Broggini, S. Marchini, E. Fontana, D. Moneta, C. Fowst, and C. Geroni, Anticancer Drugs 15, 1 (2004).
102. C. Geroni, S. Marchini, and P. Cozzi, Cancer Res. 62, 2332 (2002).
103. References DNA Structure, http://www.celltherapeutics.com/pdf/Brost- Facts-4pg.pdf
104. C. DeBoer, P.A. Meulman, R.J. Wnuk, and D.H. Peterson, J. Antibiot. (Tokyo) 23, 442 (1970).
105. K. Sasaki, K.L. Rinehart Jr, G. Slomp, M.F. Grostic, and B.C. Olson, J. Am. Chem. Soc. 92, 7591 (1970).
106. K.S. Bisht, M. Bradbury, and D. Mattson, Cancer Res. 63, 8984 (2003).
107. G. Kaur, D. Belotti, and A.M. Burger, Clin. Cancer Res. 10, 4813 (2004).
108. V. Sandor, S. Bakke, and R.W. Robey, Clin. Cancer Res. 8, 718 (2002).
109. T. Shiraga, Z. Tozuka, R. Ishimura, A. Kawamura, and A. Kagawama, Biol. Pharm. Bull. 28, 124 (2005).
110. W. Zhou and W.G. Zhu, Curr. Cancer Drug Targets 9, 91 (2009).
111. C.M. Starks, Y. Zhou, F. Liu, and P.J. Licari, J. Nat. Prod. 66, 1313 (2003).
112. S. Goodin, M.P. Kane, and E.H. Rubin, J. Clin. Oncol. 22, 2015 (2004).
113. N. Rizvi, M. Villalona-Calere, and T. Lynch, Lung Cancer. 49, S266 (2005).
114. J.J. Lee and W.K. Kelly, Nat. Clin. Pract. Oncol. 6(2), 85 (2009).
115. W.K. Kelly, Urol. Oncol. 29, 358 (2011).
116. N. Denduluri, J.A. Low, J.J. Lee, A.W. Berman, J.M. Walshe, U. Vatas, C.K. Chow, S.M. Steinberg, S.X. Yang, and S.M. Swain, J. Clin. Oncol. 25, 3421 (2007).
117. J.J. Lee and S.M. Swain, Clin. Cancer Res. 14, 1618 (2008).
118. E. Chun, C.K. Han, J.H. Yoon, T.B. Sim, Y.K. Kim, and K.Y. Lee, Int. J. Cancer 114, 124 (2005).
119. L. Hou, D. Mori, Y. Takase, P. Meihua, K. Kai, and O. Tokunaga, Pathol. Int. 59, 448 (2009).
120. E.J. Kim and W.H. Shin, Biol. Pharm. Bull. 28, 217 (2005).
121. S.G. Bernier, D.D. Lazarus, and E. Clark, Proc. Natl. Acad. Sci. USA 101, 10768 (2004).
122. A.C. Cooper, R.M. Karp, E.J. Clark, N.R. Taghizadeh, J.G. Hoyt, M.T. Labenski, M.J. Murray, G. Hannig, W.F. Westlin, and C.D. Thompson, Clin. Cancer Res. 12, 2583 (2006).
123. T.C. McMorris and M. Anchel, J. Am. Chem. Soc. 87, 1594 (1965).
124. T.C. McMorris, M.J. Kelner, W. Wang, J. Yu, L.A. Estes, and R. Taetle, J. Nat. Prod. 59, 896 (1996).
125. J. Wang, T. Wiltshire, and Y. Wang, J. Biol. Chem. 279, 39584 (2004).
126. M.V. Seiden, A.N. Gordon, D.C. Bodurka, U.A. Matulonis, R.T. Penson, E. Reed, D.S. Alberts, G. Weems, M. Cullen, and W.P. McGuire, Gynecol. Oncol. 101, 55 (2006).
127. V. Poindessous, F. Koeppel, E. Raymond, E. Cvitkovic, S.J. Waters, and A.K. Larsen, Int. J. Oncol. 23, 1347 (2003).
128. V. Poindessous, F. Koeppel, E. Raymond, M. Comisso, S.J. Waters, and A.K. Larsen, Clin. Cancer Res. 9, 2817 (2003).
129. Y. Kotake, K. Sagane, T. Owa, Y. Mimori-Kiyosue, H. Shimizu, M. Uesugi, Y. Ishihama, M. Iwata, and Y. Mizui, Nat. Chem. Biol. 3, 570 (2007).
130. T. Sakai, N. Asai, A. Okuda, N. Kawamura, and Y. Mizui, J. Antibiot (Tokyo) 57, 180 (2004).
131. E.G. Folco, K.E. Coil, and R. Reed, Genes Dev. 25, 440 (2011).
132. M. Konishi, K. Sugawara, F. Kofu, Y. Nishiyama, K. Tomita, T. Miyaki, and H. Kawagushi, J. Antibiot. (Tokyo) 39, 784 (1986).
133. X. Salas and J. Portugal, FEBS Lett. 292, 223 (1991).
134. A.J. Primeau, A. Rendon, D. Hedley, L. Lilge, and I.F. Tannock, Clin. Cancer Res. 11, 8782 (2005).
135. Valstar,
136. Y. Zou, Y.H. Ling, and T. Nguyen, Cancer Res. 54, 1479 (1994).
137. Waldemar Priebe brain tumours-from biology to therapy, Warsaw, Poland, 2012), pp. 28-30.
138. Clinicaltrials.gov: A service of the U.S. National Institutes of Health, Clinical- Trials.gov Identifier: NCT00538343.
139. A.M. Bos, E.G. de Vries, P. Dombernovsky, S. Aamdal, D.R. Uges, D. Schrijvers, J. Wanders, M.W. Roelvink, A.R. Hanauske, S. Bortini, A. Capriati, A.E. Crea, and J.B. Vermorken, Cancer Chemother. Pharmacol. 48, 361 (2001).
140. F. Caponigro, P. Willemse, R. Sorio, A. Floquet, S. van Belle, J. Demol, R. Tambaro, A. Comandini, A. Capriati, S. Adank, and J. Wanders, Invest. New Drugs 23, 85 (2005).
141. L. Quintieri, M. Fantin, P. Palatini, D.S. Martin, A. Rosato, M. Caruso, C. Geroni, and M. Floreani, Biochem. Pharmacol. 76, 784 (2008).
142. R.H. Feling, G.O. Buchanan, T.J. Mincer, C.A. Kauffman, P.R. Jensen, and W. Fenical, Angew. Chem Int. Ed. Engl. 42, 355 (2003).
143. A. Lechner, A.S. Eusta'quio, A.M. Tobias, M.H. Gulder, and B.S. Moore, Chem. Biol. 18, 1527 (2011).
144. S. Omura, Y. Iwai, A. Hirano, A. Nakagawa, J. Awaya, H. Tsuchiya, Y. Takahashi, and R. Masuma, J. Antibiot. (Tokyo) 30, 275 (1977).
145. Y.B. Chen and A.S. LaCasce, Exp. Opin. Inv. Drugs 17, 939 (2008).
146. D.J. Propper, A.C. McDonald, A. Man, P. Thavasu, F. Balkwill, J.P. Braybrooke, F. Caponigro, P. Graf, C. Dutreix, R. Blackie, S.B. Kaye, T.S. Ganesan, D.C. Talbot, A.L. Harris, and C. Twelves, J. Clin. Oncol. 19, 1484 (2001).
147. T. Fischer, R.M. Stone, D.J. Deangelo, I. Galinsky, E. Estey, C. Lanza, E.G. Ehninger, E.J. Feldman, G.J. Schiller, V.M. Klimek, S.D. Nimer, D.G. Gilliland, C. Dutreix, A. Huntsman-Labed, J. Virkus, and F.J. Giles, J. Clin. Oncol. 28, 4339 (2010).
148. Ng. Yuen-Keng, E.Y.L. Wong, C.P.Y. Lau, J.P.L. Chan, S.C.C. Wong, A.S.K. Chan, M.P.C. Kwan, S.W. Tsao, C.M. Tsang, P.B.S. Lai, A.T.C. Chan, and V.W.Y. Lui, Invest. New Drugs 30, 48 (2012).
149. S.R. Chandana, C.M. Leece, K.A. Gallo, B.V. Madhukar, and B.A. Conley, Cancer Metastat. Rev. 3, 1 (2010).
150. S. Park, N. Chapuis, J. Tamburini, V. Bardet, P.C. Lefebvre, L. Willems, A. Green, P. Mayeux, C. Lacombe, and D. Bouscar, Haematologica 95, 819 (2010).
151. W. Bergmann and R.J. Feeney, J. Org. Chem. 16, 981 (1951).
152. W. Bergmann and D.C. Burke, J. Org. Chem. 21, 226 (1956).
153. W. Bergmann and M.F. Stempien, J. Org. Chem. 22, 1575 (1957).
154. C.J. Suckling, Sci. Prog. 75, 323 (1991).
155. P.R. Jensen and W. Fenical, in Drugs from the Sea, edited by N. Fusetani (Karger, Basel, Switzerland, 2000), pp. 6-29.
156. D.J. Newman and G.M. Cragg, Curr. Med. Chem. 11, 1693 (2004).
157. D.J. Newman and G.M. Cragg, J. Nat. Prod. 67, 1216 (2004).
158. G. Taraboletti, M. Poli, and R. Dossi, Br. J. Cancer 90, 2418 (2004).
159. T. Natori, M. Morita, K. Akimoto, and Y. Koezuka, Tetrahedron 50, 2771 (1994).
160. D.J. Newman, The Bryostatins. in Anticancer Agents from Natural. Products, edited by G.M Cragg, D.G.I. Kingston, D.J. Newman, (CRC Press, Boca Raton, FL, 2005), pp. 137-150.
161. S. Honore, K. Kamath, D. Braguer, L. Wilson, C. Briand, and M.A. Jordan, Mol. Cancer Ther. 2, 1303 (2003).
162. R.J. Capon, Eur. J. Org. Chem., 633 (2001).
163. B. Haefner, Drug Discov. Today 8, 536 (2003).
164. M.A. Jordan, K. Kamath, and T. Manna, Mol. Cancer Ther. 4, 1086 (2005).
165. J.M. Jimeno, D. Garcia-Gravalos, J. Avila, B. Smith, and W. Grant, Clin. Cancer Res. 5, 3792 (1999).
166. R. Cuadros, E.M. Garcini, F. Wandosell, G. Faircloth, J.M. Ferna'ndez, and J. Avila, Cancer Lett. 152, 23 (2000).
167. H. Ueda, H. Nakajima, Y. Hori, T. Fujita, M. Nishimura, T. Goto, and M. Okuhara, J. Antibiot. 47, 301 (1994).
168. H. Ueda, H. Nakajima, Y. Hori, T. Goto, and M. Okuhara, Biosci. Biotechnol. Biochem. 58, 1579 (1994).
169. H.C.R. Wang, Drugs Future 24, 1184 (1999).
170. K.M. VanderMolen, W. McCulloch, C.J. Pearce, and N.H. Oberlies, J. Antibiot. 64, 525 (2011).
171. P.A. Meyers, C.L. Schwartz, M.D. Krailo, J.H. Healey, M.L. Bernstein, D. Betcher, W.S. Ferguson, M.C. Gebhardt, A.M. Goorin, M. Harris, E. Kleinerman, M.P. Link, H. Nadel, M. Nieder, G.P. Siegal, M.A. Weiner, R.J. Wells, R.B. Womer, and H.E. Grier, J. Clin. Oncol. 26, 633 (2008).
172. V. Brinkmann, A. Billich, T. Baumruker, P. Heining, R. Schmouder, G. Francis, S. Aradhye, and P. Burtin, Nat. Rev. Drug Discov. 9, 883 (2010).
173. C.R. Strader, C.J. Pearce, and N.H. Oberlies, J. Nat. Prod. 74, 900 (2011).
174. S.J. White, L.M. Kasman, and M.M. Kelly, Free Rad. Biol. Med. 43, 1313 (2007).
175. S. Busquets, E. Ametller, and G. Fuster, Cancer Lett. 245, 144 (2007).
176. C. Nathan, Nature 431, 899 (2004).
177. S.S. Girija and N.P. Surendra, Oppo. Chall. Scope Nat. Prod. Med. Chem., 63 (2011).
178. G.S. Singh, Mini Rev. Med. Chem. 4, 69 (2004).
179. G.S. Singh, Mini Rev. Med. Chem. 4, 93 (2004).
180. G.G. Zhanel, K. Homenuik, and K. Nichol, Drugs 64, 63 (2004).
181. G.G. Zhanel, M. Walters, and A. Noreddin, Drugs 62, 1771 (2002).
182. A. Stucki, P. Gerber, F. Acosta, M. Cottagnoud, P. Cottagnoud, L. Jiang, P. Nguyen, D. Wachtel, G. Wang, and L.T. Phan, J. Antimicrob. Chemother. 61, 665 (2008).
183. J. Dreier, E. Amantea, L. Kellenberger, and M.G.P. Page, Antimicrob. Agents Chemother. 51, 4361 (2007).
184. J.E. Hochlowski, S.J. Swanson, L.M. Ranfranz, D.N. Whittern, A.M. Buko, and J.B. McAlpine, J. Antibiot. (Tokyo) 40, 575 (1987).
185. D. Parish and N. Scheinfeld, Curr. Opin. Invest. Drugs 9, 201 (2008).
186. K.S. Thomson and E.S. Moland, J. Antimicrob. Chemother. 54, 557 (2004).
187. Y. Ueda, K. Kanazawa, K. Eguchi, K. Takemoto, Y. Eriguchi, and M. Sunagawa, Antimicrob. Agents Chemother. 49, 4185 (2005).
188. M. Minamimura, Y. Taniyama, E. Inoue, and S. Mitsuhashi, Antimicrob. Agents Chemother. 37, 1547 (1993).
189. J.P. Gettig, C. Crank, and A.H. Philbrick, Ann. Pharmacother. 42, 80 (2008).
190. M. Casal, M. Vaquero, H. Rinder, E. Tortoli, J. Grosset, S. Rusch-Gerdes, J. Gutierrez, and V. Jarlier, Microb. Drug Resist. 11, 62 (2005).
191. H.F. Chambers, Emerg. Infect. Dis. 7, 178 (2005).
192. R. Nair, T. Kalariya, and S. Chanda, Turk. J. Biol. 29, 41 (2005).
193. R. Dabur, A. Gupta, T.K. Mandal, D.D. Singh, V. Bajpai, A.M. Gurav, and G. Lavekar, Afr. J. Tradit. 4, 313 (2007).
194. M. Khond, J. Bhosale, T. Arif, T.K. Mandal, M.M. Padhi, and R. Dabur, Mid. East. J. Sci. Res. 4, 271 (2009).
195. S.L. Sukanya, J. Sudisha, P. Hariprasad, S.R. Niranjana, H.S. Prakash, and S.K. Fathima, Afr. J. Biotechnol. 8, 6677 (2009).
196. R. Valsaraj, P. Pushapngadan, U.W. Smitt, A. Adgersen, and U. Nyman, J. Ethnopharmacol. 58, 75 (1997).
197. H.N. Thatoi, S.K. Panda, S.K. Rath, and S.K. Dutta, Asian J. Plant Soc. 7, 260 (2008).
198. M.D. Richardson, J. Antimicrob. Chemother. 56, 5 (2005).
199. C. Pierce, P. Uppulori, A.R. Tristan Jr, F. Wormley, E. Mowat, G. Ramage, and J.L. Lapez-Ribot, Nat. Protocol. 3, 1494 (2008).
200. L. Ostrosky-Zeichner, K.A. Marr, J.H. Rex, and S.H. Cohen, Clin. Infect. Dis. 37, 415 (2003).
201. J. Mittendorf, F. Kunisch, M. Matzke, H.C. Militzer, A. Schmidt, and W. Schonfeld, Bioorg. Med. Chem. Lett. 13, 433 (2003).
202. V. Petraitis, R. Petraitiene, A.M. Kelaher, A.A. Sarafandi, T. Sein, D. Mickiene, J. Bacher, A.H. Groll, and T.J. Walsh, Antimicrob. Agents Chemother. 48, 3959 (2004).
203. R.E. Schultes, The Kingdom of Plants. in Medicines from the Earth, edited by W.A.R. Thomson, (McGraw-Hill Book Co, New York, 1978), p. 208.
204. K. Stadler, V. Masignani, M. Eickmann, S. Becker, S. Abrignani, H.D. Klenk, and R. Rappuoli, Nat. Rev. Microbiol. 1, 209 (2003).
205. T. Fujioka, Y. Kashiwada, R.E. Kilkuskie, L.M. Cosentino, L.M. Ballas, J.B. Jiang, W.P. Janzen, I.S. Chen, and K.H. Lee, J. Nat. Prod. 57, 243 (1994).
206. J.Z. Wu, C.C. Lin, and Z. Hong, J. Antimicrob. Chemother. 52, 543 (2003).
207. G.R. Foster, Semin. Liver Dis. 24, 97 (2004).
208. E. Arai, Y. Nishida, J. Wasa, H. Urakawa, L. Zhuo, K. Kimata, E. Kozawa, N. Futamura, and N. Ishiguro, Cancer Br. J. Cancer 105, 1839 (2011).
209. W.E. Robinson, M. Reinecke, S. Abdel- Malek, Q. Jia, and S. Chow, Proc. Natl. Acad. Sci. USA. 93, 6326 (1996).